Exercise and Erectile Dysfunction: What the Clinical Evidence Actually Says

Exercise and Erectile Dysfunction: What the Clinical Evidence Actually Says

James Harmon

James Harmon, Medical Content Advisor

Contributing Editor

March 28, 2026
erectile dysfunctionexerciseaerobic trainingnitric oxidemen's healthlifestyle

If you've been told to "just exercise more" to fix erectile dysfunction, you've probably wondered whether that advice has any real science behind it — or whether it's the same empty prescription as "sleep better" and "reduce stress." The answer, as it turns out, is more substantive than most men expect.

Aerobic exercise has a direct, mechanistic relationship with erectile function. Clinical data published in peer-reviewed journals now quantify that relationship precisely. Understanding why exercise works — and how much you need — can help you make smarter decisions about your lifestyle, your treatment options, and whether you're leaving performance on the table.


The Vascular Root of Most Erectile Dysfunction

Before examining exercise, it helps to understand what's actually failing during ED. In the majority of cases — particularly in men over 35 — the problem is vascular, not psychological.

An erection depends on a cascade of events that begins in the endothelium, the thin cellular lining of your blood vessels. When arousal signals arrive, the endothelium releases nitric oxide (NO), a signalling molecule that causes smooth muscle in the penile arteries to relax. That relaxation allows blood to flood the corpus cavernosum — the spongy tissue responsible for rigidity — while venous outflow is temporarily restricted.

Endothelial inflammation and dysfunction disrupts this process at the source. When the endothelium is damaged — by cardiovascular risk factors, metabolic disease, chronic inflammation, or sedentary lifestyle — nitric oxide production drops. The arterial response is blunted. Blood flow is inadequate. This is why ED is sometimes described clinically as "penile angina": the penile vasculature is often the first vascular bed to show signs of systemic endothelial disease, frequently preceding coronary events by three to five years.

That context makes the exercise data much easier to interpret.


What a 2023 Meta-Analysis Found

A landmark 2023 meta-analysis published in The Journal of Sexual Medicine (Khera, Bhattacharyya, and Miller) analysed randomised controlled trial data on aerobic exercise and erectile function. The findings were clinically meaningful, not just statistically significant.

Using the International Index of Erectile Function – Erectile Function subscale (IIEF-EF) as the outcome measure — a validated 30-point questionnaire where higher scores indicate better function — the analysis found that aerobic exercise consistently improved erectile function scores. Critically, the benefit was dose-dependent by baseline severity:

  • Mild ED: IIEF-EF improvement of approximately 2.3 points
  • Moderate ED: IIEF-EF improvement of approximately 3.3 points
  • Severe ED: IIEF-EF improvement of approximately 4.9 points

Men with more severe baseline dysfunction showed the greatest gains — suggesting that the vascular underpinnings of ED are particularly responsive to aerobic intervention. The minimum clinically important difference on the IIEF-EF is typically considered to be 2–4 points, meaning these improvements crossed the threshold of real-world impact.

The mechanism? Aerobic exercise directly improves endothelial function through increased nitric oxide production and endothelial progenitor cell growth — the same cellular pathway that PDE5 inhibitors work downstream of.


Exercise vs. PDE5 Inhibitors: What a 2024 Review Added

A 2024 systematic review and meta-analysis published in Andrology (Chen et al.) took a different lens: examining what happens when men with ED pursue exercise without concurrent PDE5 inhibitor therapy. The findings reinforced the standalone value of physical activity.

In men not receiving pharmacological treatment, aerobic training alone produced significant improvements in erectile function. Resistance training and combined modalities showed benefits as well, but aerobic exercise consistently outperformed other training types in erectile function outcomes — likely because of its greater effect on cardiovascular capacity, endothelial function, and systemic nitric oxide availability.

This research matters for two groups of men: those who want to understand whether lifestyle changes can make a real difference before starting medication, and those already using treatment who want to know whether exercise compounds the benefit. The short answer to the second question appears to be yes — the mechanisms are complementary, not redundant.


What Type of Exercise, and How Much

Not all exercise affects erectile function equally. The clinical evidence points clearly toward aerobic training as the primary modality:

Effective aerobic formats include:

  • Brisk walking or jogging (40–60 minutes, 3–5 times per week)
  • Cycling — though prolonged pressure on the perineal region from narrow saddles has been associated with ED in some studies, so bike fit matters
  • Swimming and elliptical training
  • Rowing

Intensity: Moderate-to-vigorous intensity (roughly 60–80% of maximum heart rate) appears to produce the most reliable improvements in vascular markers and IIEF-EF scores. Light walking is better than nothing but unlikely to produce clinically meaningful change.

Duration before results: Most intervention studies ran 8–24 weeks before endpoint measurement. Clinical studies suggest meaningful improvements in erectile function become measurable after 8–12 weeks of consistent training — this is not a one-week fix.

Pelvic floor training — specifically Kegel exercises — has also shown benefits in some ED research by improving the contractile strength of the ischiocavernosus and bulbocavernosus muscles involved in maintaining rigidity. Some protocols combine aerobic training with pelvic floor work for additive effect.


Lifestyle Factors That Compound — or Undermine — the Gains

Exercise improves erectile function through multiple pathways simultaneously: endothelial health, reduced systemic inflammation, improved testosterone availability, lower body fat (adipose tissue aromatises testosterone to oestrogen), better insulin sensitivity, and reduced sympathetic nervous system tone. But those gains can be undermined by lifestyle factors that work in the opposite direction.

Sedentary hours outside of exercise: Research suggests that sitting for prolonged periods compresses perineal vasculature and impairs penile oxygenation independent of formal workout frequency. Men who exercise 45 minutes daily but sit for 10+ hours may partially offset the gains.

Alcohol: Chronic and acute alcohol intake disrupts nitric oxide signalling, impairs testosterone, and has a direct vasodilatory-then-vasoconstrictive effect that can cause situational ED.

Sleep deprivation: Nocturnal penile tumescence — involuntary erections during REM sleep — serves a physiological function: oxygenating penile tissue and maintaining smooth muscle health. Poor sleep reduces these events, and longitudinal data show sleep-disordered men have elevated ED risk.

Smoking: Probably the single largest modifiable vascular risk factor. Smoking accelerates endothelial damage, reduces nitric oxide bioavailability, and stiffens arterial walls. Studies consistently show higher ED prevalence and severity in smokers.

The compounding effect of multiple healthy habits is difficult to overstate. Exercise works — but it works best as part of a comprehensive approach.


When Exercise Is Not Enough

Clinical evidence supports exercise as a legitimate intervention for erectile dysfunction — particularly for men with mild-to-moderate ED driven by vascular risk factors. But lifestyle change has limits, and recognising those limits is part of evidence-based care.

For men with moderate or severe ED, or for those who want reliable improvement faster than 12 weeks of aerobic training, clinically-formulated pharmacological options remain the gold standard. PDE5 inhibitors — tadalafil, sildenafil, and vardenafil — work downstream of the same nitric oxide pathway that exercise targets upstream. They don't replace the vascular benefits of physical activity; they operate alongside them.

OnyxMD's EPIQ CHEWS take this logic further: a daily formulation combining Tadalafil 5mg and Vardenafil 5mg, designed to maintain baseline PDE5 inhibition while lifestyle interventions rebuild underlying vascular health. Daily-dose tadalafil, in particular, has been studied for its cumulative endothelial effects — supporting a "treat and rehabilitate" approach rather than purely on-demand use.


The Bottom Line

Exercise is not a placebo recommendation for erectile dysfunction. A 2023 meta-analysis in The Journal of Sexual Medicine confirmed clinically meaningful IIEF-EF improvements across all baseline severity categories, and a 2024 review in Andrology validated those benefits in men not using PDE5 inhibitors. Aerobic training — consistent, moderate-to-vigorous intensity, over at least 8–12 weeks — works through the same nitric oxide and endothelial pathways that underlie most vascular ED.

That does not mean exercise is a substitute for evidence-based treatment when it's needed. The smartest approach is both: build the vascular foundation through lifestyle, and work with a physician to determine whether pharmacological support makes sense in the meantime.


If you're ready to explore clinically-formulated options, OnyxMD offers physician-supervised treatment plans starting with a free online assessment at questionnaire.getonyxmd.com.

Explore all treatment options on our products page or browse more evidence-based guides on the OnyxMD blog.


These statements have not been evaluated by the FDA. This content is for informational purposes only and does not constitute medical advice.

Medical Disclaimer: The information provided on this website is for educational and informational purposes only and is not intended as medical advice. OnyxMD services should not be used to diagnose, treat, cure, or prevent any disease or medical condition. Always consult with a qualified healthcare provider before beginning any supplement regimen or health program.

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Individual Results: Results may vary. The experiences and testimonials presented on this website are individual results that may not be typical. Your experience may be different.

Telehealth Services: OnyxMD provides telehealth services in 47 states (excluding AK, MS, NJ) through licensed healthcare providers via our partner Beluga Health, P.A. Services are subject to clinical evaluation and may not be appropriate for all individuals. Prescriptions fulfilled by Strive Pharmacy LLC (License #99-9817) and EPIQ SCRIPTS LLC.

James Harmon

Written by

James Harmon, Medical Content Advisor

Contributing Editor · OnyxMD Editorial Team

James Harmon is a contributing editor at OnyxMD, focusing on men's preventive health, cardiovascular wellness, and sexual function. He draws on a background in health journalism and public health to translate complex clinical research into clear, actionable articles.